Ablation of paroxysmal and persistent atrial fibrillation with multielectrode phased radiofrequency duty-cycled catheters: Long-term results from a large cohort of patients

Journal of Cardiovascular Medicine

Volumn 14, Issue 12, 2013, Pages 879-885

  Nardi, Stefano ^a   Argenziano, Luigi ^a   Cappato, Riccardo ^b   De Martino, Giuseppe ^c   Esposito, Cristina ^d   Scaglione, Mariano ^a   Borrello, Francesco ^e   Maglia, Giampiero ^e  

^a Pineta Grande Hospital   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c Cristo Re Hospital   (Italy)

^d S MARIA HOSPITAL   (Italy)

^e PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

Atrial fibrillation; Catheter ablation; Duty cycled radiofrequency; Pulmonary vein isolation

Indexed keywords

AMIODARONE; FLECAINIDE; PROPAFENONE; SOTALOL;

ADULT; AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARTERIOVENOUS FISTULA; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVERSION; CATHETER; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMORBIDITY; DYSLIPIDEMIA; ELECTRODE; FEMALE; FEMORAL ARTERIOVENOUS FISTULA; FLUOROSCOPY; FOLLOW UP; GENERATOR; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIAL DIAMETER; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOMA; HOLTER MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIELECTRODE PHASED RADIOFREQUENCY DUTY CYCLED CATHETER; PAROXYSMAL HEART ATRIUM FIBRILLATION; PATIENT SAFETY; PERSISTENT ATRIAL FIBRILLATION; PREDICTIVE VALUE; PULMONARY VEIN ISOLATION; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; TACHYCARDIA;

AGED; ATRIAL FIBRILLATION; CARDIAC CATHETERS; CATHETER ABLATION; COHORT STUDIES; ELECTROCARDIOGRAPHY, AMBULATORY; EQUIPMENT DESIGN; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PULMONARY VEINS; RECURRENCE; TREATMENT OUTCOME;

EID: 84890122184     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328360931a     Document Type: Article

References (27)

1. Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104:2118-2150.
2. Fisher JD, Spinelli MA, Mookherjee D, Krumerman AK, Palma EC. Atrial fibrillation ablation: reaching the mainstream. Pacing Clin Electrophysiol 2006; 29:523-537.
3. Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006; 354:934-941.
4. Takahashi Y, O'Neill MD, Hocini M, et al. Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. J Am Coll Cardiol 2007; 49:1306-1314.
5. Knecht S, Hocini M, Wright M, et al. Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J 2008; 29:2359-2366.
6. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004; 43:2044-2053.
7. O'Neill MD, Wright M, Knecht S, et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J 2009; 30:1105-1112.
8. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design. J Interv Cardiac Electrophysiol 2012; 33:171-257.
9. Scharf C, Boersma L, Davies W, et al. Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy. J Am Coll Cardiol 2009; 54:1450-1456.
10. Boersma LV, Wijffels MC, Oral H, Wever EF, Morady F. Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm 2008; 5:1635-1642.
11. Wijffels M, Van Oosterhout M, Boersma L, et al. Characterization of in vitro and in vivo lesions made by a novel multichannel ablation generator and a circumlinear decapolar ablation catheter. J Cardiovasc Electrophysiol 2009; 20:1142-1148.
12. Mulder AA, Wijffels MC, Wever EF, Boersma LV. Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2-year follow-up and predictors of failure. Europace 2012; 14:818-825.
13. Mulder AA, Wijffels MC, Wever EF, Boersma LV. Pulmonary vein anatomy and long-term outcome after multielectrode pulmonary vein isolation with phased radiofrequency energy for paroxysmal atrial fibrillation. Europace 2011; 13:1557-1561.
14. Scharf C, Ng GA, Wieczorek M, et al. European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation. Europace 2012; 14:1700-1707.
15. Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111:1100-1105.
16. Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3:32-38.
17. Gaita F, Leclercq JF, Schumacher B, et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J Cardiovasc Electrophysiol 2011; 22:961-968.
18. Herrera Siklody C, Deneke T, Hocini M, et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol 2011; 58:681-688.
19. Deneke T, Shin DI, Balta O, et al. Post-ablation asymptomatic cerebral lesions: long-term follow-up using magnetic resonance imaging. Heart Rhythm 2011; 8:1705-1711.
20. Bendszus M, Stoll G. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol 2006; 5:364-372.
21. Kruis RW, Vlasveld FA, Van Dijk D. The (un)importance of cerebral microemboli. Semin Cardiothorac Vasc Anesth 2010; 14:111-118.
22. Michaud GF. Silent cerebral embolism during catheter ablation of atrial fibrillation: how concerned should we be? Circulation 2010; 122:1662-1663.
23. De Greef Y, Tavernier R, Raeymaeckers S, et al. Prevalence, characteristics, and predictors of pulmonary vein narrowing after isolation using the pulmonary vein ablation catheter. Circ Arrhythm Electrophysiol 2012; 5:52-60.
24. Wieczorek M, Hoeltgen R, Akin E, Salili AR, Oral H, Morady F. Results of short-term and long-term pulmonary vein isolation for paroxysmal atrial fibrillation using duty-cycled bipolar and unipolar radiofrequency energy. J Cardiovasc Electrophysiol 2010; 21:399-405.
25. Bulava A, Haniš J, Sitek D, et al. Catheter ablation for paroxysmal atrial fibrillation: a randomized comparison between multielectrode catheter and point-by-point ablation. Pacing Clin Electrophysiol 2010; 33:1039-1046.
26. Bittner A, Mönnig G, Zellerhoff S, et al. Randomized study comparing dutycycled bipolar and unipolar radiofrequency with point by point ablation in pulmonary vein isolation. Heart Rhythm 2011; 8:1383-1390.
27. Choo WK, Farwell D, Harris S, et al. Experience of atrial fibrillation ablation in a new cardiac centre using three-dimensional mapping and multielectrode duty-cycled radiofrequency ablation. Arch Cardiovasc Dis 2011; 104:396-402.